Mead Johnson Nutrition Company (MJN): $1.22 million was the positive money flow into the stock on Wednesday and the up/down ratio of ticks was also in favor of the bulls at 1.66. The value of trades done on upticks was $3.08 million, whereas, trades done on downticks were valued at $1.86 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $0.1 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $0.1 million. Mead Johnson Nutrition Company (MJN) fell $0.16 traded at $90.97, a change of -0.18% over the previous day. The stock is -0.45% for the week.
Also, Equity Analysts at the Bank of America upgrades the rating on Mead Johnson Nutrition Company (NYSE:MJN). The brokerage firm has issued a Neutral rating on the shares. The shares were previously rated Underperform. The rating by the firm was issued on July 13, 2016.
Mead Johnson Nutrition Company (NYSE:MJN): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $91.24 and $90.74 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $91.40. The buying momentum continued till the end and the stock did not give up its gains. It closed at $91.24, notching a gain of 0.12% for the day. The total traded volume was 456,735 . The stock had closed at $91.13 on the previous day.
The stock has recorded a 20-day Moving Average of 2.32% and the 50-Day Moving Average is 6.44%. In a related news, Stratton Christoper Richard, officer (SVP and President, Asia) of Mead Johnson Nutrition Co, unloaded 33,730 shares at an average price of $86.68 on May 2, 2016. The total amount of the transaction was worth $2,923,716, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.